CO4750644A1 - NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS - Google Patents
NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLSInfo
- Publication number
- CO4750644A1 CO4750644A1 CO96033541A CO96033541A CO4750644A1 CO 4750644 A1 CO4750644 A1 CO 4750644A1 CO 96033541 A CO96033541 A CO 96033541A CO 96033541 A CO96033541 A CO 96033541A CO 4750644 A1 CO4750644 A1 CO 4750644A1
- Authority
- CO
- Colombia
- Prior art keywords
- preparation according
- medicated
- preparation
- ethanol
- solvent
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Preparado medicamentoso para producir aerosoles 5 exentos de gaspropulsor que contiene una sustancia farmacológicamente activa así como eventualmente coadyuvantes y/o sustancias saboreantes farmacológicamente inocuos, caracterizado porque el preparado medicamentoso contiene como disolvente etanol al menos al 70% (v/v). Preparado medicamentoso según la reivindicación 1, caracterizado porque como disolvente contiene etanol al 96% (v/v). Preparado medicamentoso según la reivindicación 1 o 2, caracterizado porque la sustancia activa está determinada para la aplicación por inhalación y se compone del grupo de los betamiméticos, anticolinérgicos, antialérgicos y/o antagonistas de PAF. Preparado medicamentos para producir aerosoles exentos de gas propulsor que contienen un esteroide así como eventualmente coadyuvantes y/o sustancias saboreantes farmacológicamente inocuos, caracterizado porque el preparado medicamentoso contiene como disolvente etanol al menos al 85% (v/v) y eventualmente un formador de complejos. Preparado medicamentoso según la reivindicación 4, caracterizado porque el disolvente es etanol al 96% (v/v). Preparado medicamentoso según la reivindicación 5, caracterizado porque el formador de complejos es EDTA o una sal del mismo. Preparado medicamentoso según la reivindicación 4 o 6, caracterizado porque la cantidad de formador de complejos oscila entre 0,1 y 5 mg/100 ml de solución. Preparado medicamentoso según una de las reivindicaciones 4 a 7, caracterizado porque el valor del pH del preparado está ajustado a un valor entre 3,2 y 4,5.Drug preparation to produce gas-propellant-free aerosols containing a pharmacologically active substance as well as possibly adjuvants and / or pharmacologically safe flavoring substances, characterized in that the drug preparation contains at least 70% (v / v) ethanol solvent. Medicated preparation according to claim 1, characterized in that it contains 96% (v / v) ethanol as a solvent. Medicated preparation according to claim 1 or 2, characterized in that the active substance is determined for the application by inhalation and is made up of the group of betamimetics, anticholinergics, antiallergics and / or PAF antagonists. Drug preparation to produce propellant gas-free aerosols containing a steroid as well as possibly adjuvants and / or pharmacologically safe flavoring substances, characterized in that the drug preparation contains at least 85% (v / v) ethanol and eventually a complex-forming solvent. . Medicated preparation according to claim 4, characterized in that the solvent is 96% (v / v) ethanol. Drug preparation according to claim 5, characterized in that the complexer is EDTA or a salt thereof. Medicated preparation according to claim 4 or 6, characterized in that the amount of complex former ranges from 0.1 to 5 mg / 100 ml of solution. Medicated preparation according to one of claims 4 to 7, characterized in that the pH value of the preparation is adjusted to a value between 3.2 and 4.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO96033541A CO4750644A1 (en) | 1996-06-26 | 1996-06-26 | NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CO96033541A CO4750644A1 (en) | 1996-06-26 | 1996-06-26 | NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4750644A1 true CO4750644A1 (en) | 1999-03-31 |
Family
ID=40930130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO96033541A CO4750644A1 (en) | 1996-06-26 | 1996-06-26 | NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS |
Country Status (1)
Country | Link |
---|---|
CO (1) | CO4750644A1 (en) |
-
1996
- 1996-06-26 CO CO96033541A patent/CO4750644A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002614A1 (en) | NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS | |
UY24813A1 (en) | NEW AQUEOUS MEDICATION PREPARATIONS FOR THE PRODUCTION OF GAS PROPELLER FREE SPRAYS | |
AR033444A1 (en) | SOLID DOSAGE FORM FOR THE ORAL ADMINISTRATION OF AN ACTIVE NICOTINE COMPOUND, THROUGH THE MUCOSE AND USE OF AN ACTIVE NICOTINE COMPOUND TO PREPARE IT | |
EE200300033A (en) | Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them | |
DE60114571D1 (en) | PREPARATIONS WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
RU98101470A (en) | NEW STABLE MEDICINAL COMPOSITION FOR PRODUCING AEROSOLS OF WORKING GAS | |
RU94040387A (en) | Nicotine-containing composition | |
BG105033A (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
MD1813B2 (en) | Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition | |
SE0003449D0 (en) | Anticancer compositions | |
AR046533A1 (en) | FORMULATION OF AEROSOL INTENDED FOR INHALATION, CONTAINING AN ANTI-POLINERGIC AGENT | |
EA199900991A1 (en) | MEDICAL SPRAY PREPARATIONS | |
NO962841D0 (en) | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives such as colon cancer chemopreventives and chemotherapeutic agents | |
KR960700061A (en) | PHARMACEUTICAL COMPOSITION FOR TREATING NICOTINE DEPENDENCE | |
ATE202931T1 (en) | MEDICINAL PREPARATIONS CONTAINING TAXAN DERIVATIVES | |
AR006401A1 (en) | PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES. | |
BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
EA200701805A1 (en) | COMPOSITION OF AEROSOL FOR DOSING INHALERS UNDER PRESSURE | |
ES2171459T3 (en) | NASAL ADMINISTRATION POWDER FOR PEPTIDIC PHARMACO OR PROTEINACEO. | |
CO4750644A1 (en) | NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS | |
MXPA05006528A (en) | Process for preparing combination pharmaceutical formulations using supercritical fluids. | |
AR012826A1 (en) | BIS-PLATINUM (II) COMPLEX, METHOD FOR PREPARING SUCH A COMPLEX AND USE OF THE SAME COMPLEX IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION TO TREAT TUMORS. | |
MXPA04000007A (en) | Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction. | |
SE9403389D0 (en) | Pharmaceutical composition containing derivatives of sex hormones | |
ES8200678A1 (en) | Dibenzazepine derivatives, their production and pharmaceutical compositions containing them. |